HalentZhang

Of Counsel

Hong Kong + 852.3189.7252

Connect:

Share

Halent Zhang's practice focuses on corporate finance and commercial transactions, including various listing projects in Hong Kong, Germany, and South Korea. She has extensive experience advising clients on public and private M&A, open offer, bond issues, and other general corporate and commercial matters. She also assists listed companies in their day-to-day legal regulatory and compliance matters.

Halent's experience includes advising: underwriters on the US$1.7 billion initial public offering of a joint stock commercial bank; a hair goods manufacturer on its HK$304 million initial public offering; a listed company in its US$118 million acquisition of an e-commerce technology solutions provider in the United States by way of merger; and a Chinese pharmaceutical company on its US$50 million investment and acquisition of an Israeli medical device developer.

Prior to joining Jones Day in 2015, Halent represented a listed company in its HK$2 billion acquisition of a dedicated oolong tea producer and advised a listed company on its issue of RMB491 million convertible bonds.

Experience

  • Vida Capital Partners and Ludhill Limited sell Furrion Holdings to Lippert Components, Inc.Jones Day advised Vida Capital Partners and its affiliates in the disposal of their interests in Furrion Holdings, a leading distributor of high-end appliances to original equipment manufacturers and aftermarket customers in the recreational vehicle, specialty vehicle, and marine industries, to Lippert Components, Inc.
  • AGIC Capital closes $1.2 billion fund for investments in smart industriesJones Day acted as fund formation counsel to AGIC Capital for its $1.2 billion final closing of its second fund, AGIC Fund II L.P., which will be focused on advanced industrial and medical technology investments.
  • Shanghai Junshi Biosciences completes $329 million placing of new H Shares on main board of The Stock Exchange of Hong Kong LimitedJones Day advised Shanghai Junshi Biosciences Co., Ltd. (the “Company”), a company listed on the main board of The Stock Exchange of Hong Kong Limited and the STAR Market of the Shanghai Stock Exchange, in connection with its US$329 million placing of new H Shares of the Company.
  • Junshi and Lilly to develop and commercialize antibodies for prevention and treatment of COVID-19 coronavirusJones Day represented Shanghai Junshi Biosciences Co., Ltd. in its strategic collaboration and license agreement with Eli Lilly and Company for the development, manufacturing, and commercialization of two antibodies for the prevention and treatment of the COVID-19 SARS-CoV-2 novel coronavirus.
  • Cleveland-Cliffs completes offers to exchange 6.375% Senior Notes and 7.00% Senior Notes issued by AK Steel CorporationJones Day represented Cleveland-Cliffs Inc. (“Cliffs”), a large vertically integrated producer of differentiated iron ore and steel in North America, in connection with its offers to exchange any and all 6.375% Senior Notes due 2025 and 7.00% Senior Notes due 2027 issued by AK Steel Corporation for the same aggregate principal amount of new notes issued by Cliffs’.
  • Cleveland-Cliffs issues $725 million of 6.75% Senior Secured NotesJones Day represented Cleveland-Cliffs Inc. ("Cliffs"), a large vertically integrated producer of differentiated iron ore and steel in North America, in connection with an offering of $725 million aggregate principal amount of 6.75% Senior Secured Notes due 2026.
  • CLSA Capital, CLSA, CCB International Capital, and China Galaxy complete approximate $210 million IPO on The Stock Exchange of Hong Kong Limited by Luzhou BankJones Day acted as counsel for the sole sponsor, CLSA Capital Markets Limited, and underwriters, comprising of CLSA Limited, CCB International Capital Limited, China Galaxy International Securities (Hong Kong) Co., Limited, and others, in connection with the $210 million initial public offering of H shares on The Stock Exchange of Hong Kong Limited by Luzhou Bank Co., Ltd. and concurrent Regulation S offering.
  • Shanghai Junshi Biosciences completes $450 million IPO on The Stock Exchange of Hong Kong LimitedJones Day acted as Hong Kong and U.S. counsel for Shanghai Junshi Biosciences Co., Ltd. in connection with its over $450 million initial public offering on The Stock Exchange of Hong Kong Limited and concurrent Rule 144A and Regulation S offerings.
  • Midas acquires Microlife CorporationJones Day advised Midas Fund LP, a joint venture partner in Midas Company Limited, in the acquisition by Midas Company of all of the issued and outstanding shares of Microlife Corporation by way of a 100 percent share swap, for the aggregate consideration of NT$9.3 billion (US$300.9 million).
  • AGIC Capital sells minority stake in CNCE Global Holdings (Hong Kong) Co., LimitedJones Day advised Asia-Germany Industrial Promotion Limited ("AGIC Capital"), an Asian-European private equity investor focused on industrial technology companies in the European and North American mid-market, in connection with its sale of minority stake in CNCE Global Holdings (Hong Kong) Co., Limited.
  • Hyster-Yale acquires 75% of Zhejiang Maximal Forklift TruckJones Day advised Hyster-Yale Materials Handling, Inc. in its $90 million acquisition of 75% of the outstanding shares of, and a controlling interest in, Zhejiang Maximal Forklift Company Limited from KNSN Pipe and Pile Company Limited.
  • Halcyon Capital, BOCI Asia, Hong Kong Asset Management, and Halcyon Securities complete IPO on Main Board of Hong Kong Stock Exchange of Precision Tsugami (China) Corporation LimitedJones Day advised Halcyon Capital Limited, as sole sponsor, and BOCI Asia, Hong Kong Asset Management, and Halcyon Securities, as underwriters, in connection with the initial public offering and listing on the Main Board of the Hong Kong Stock Exchange (HKSE) of Precision Tsugami (China) Corporation Limited, an established CNC high precision machine tool manufacturer in China.
  • Cardinal Health acquires leading patient product portfolio from Medtronic for $6.1 billionJones Day advised Cardinal Health on the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion in cash.
  • Evergreen Products Group completes IPO and lists on Hong Kong Stock ExchangeJones Day advised Evergreen Products Group in its initial public offering and listing on the Hong Kong Stock Exchange.
  • Automated Systems Holdings completes acquisition of Grid Dynamics International for up to US$118 million funded by rights issue and placing of convertible bondsJones Day advised Automated Systems Holdings Limited, an information technology and software company, in connection with its acquisition of Grid Dynamics International, Inc., a provider of open, scalable, next-generation e-commerce technology solutions, by way of merger at a consideration of up to US$118 million and its financing by way of a HK$193 million rights issue and placing of convertible bonds with an aggregate value of HK$350 million.
  • Foxconn obtains majority acquisition of Teleeye Holdings LimitedJones Day advised Foxconn (Far East Limited) in its acquisition of a 50.07 percent interest in Teleeye Holdings Limited and subsequent mandatory unconditional cash offer to acquire all of the remaining shares.
  • AGIC Capital as part of €925 million ($1.0 billion) investment consortium completes acquisition of KraussMaffei GroupJones Day advised AGIC Capital, as part of the investment consortium including China National Chemical Corporation and GUOXIN International Investment Corporation, in the €925 million ($1.0 billion) acquisition of KraussMaffei Group from Onex Corporation.
  • CITIC CLSA, CICC, Goldman Sachs, and Agricultural Bank of China International underwrite $1.7 billion IPO on Hong Kong Stock Exchange by China Zheshang BankJones Day acted as counsel for the underwriters, led by CITIC CLSA, China International Capital Corporation (CICC), Goldman Sachs, and Agricultural Bank of China International, on the US$1.7 billion initial public offering of China Zheshang Bank Co., Ltd. on the Main Board of the Hong Kong Stock Exchange ("HKSE").
  • Fung Teng acquires MastercraftJones Day advised Fung Teng Enterprises in its acquisition of a controlling interest and general offer for the remaining interest of Mastercraft International Holding Limited.
    • View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.